Clinical updates, including trial initiations, enrollment status and data readouts and publications: Agenus, Aileron, Amphera, Bioinvent, Concert, Cymabay, Evofem, Eyepoint, Hutchmed, Immutep, Innate, Innovent, Syneurx, Verrica, Vivoryon.